Accuray and UW-Madison establish ten-year research collaboration
Accuray and the University of Wisconsin School of Medicine and Public Health established a ten-year collaboration around adaptive radiation therapy.
Evidence notes
- The agreement focuses on the Stellar adaptive radiation therapy platform.
- The collaboration covers clinical research, education, training and adaptive-therapy development.
- It extends a relationship rooted in the technology later commercialised as TomoTherapy.
Company context
Accuray develops and manufactures robotic radiosurgery and image-guided radiation therapy systems, including the CyberKnife and helical TomoTherapy and Radixact platforms.